Follow
Roman Yatsyshyn
Roman Yatsyshyn
professor Ivano-Frankivsk National Medical University
Verified email at ifnmu.edu.ua
Title
Cited by
Cited by
Year
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from …
DH Yoo, A Racewicz, J Brzezicki, R Yatsyshyn, ET Arteaga, ...
Arthritis research & therapy 18, 1-12, 2016
2002016
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid …
JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, E Dokoupilova, ...
Annals of the Rheumatic Diseases 76 (1), 58-64, 2017
1932017
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid …
JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, E Dokoupilova, ...
Annals of the Rheumatic Diseases 76 (1), 58-64, 2017
1932017
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid …
JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, E Dokoupilova, ...
Annals of the Rheumatic Diseases 76 (1), 58-64, 2017
1932017
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with …
JS Smolen, JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, ...
Annals of the rheumatic diseases 77 (2), 234-240, 2018
1312018
Phase III Randomized Study of SB 5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis
ME Weinblatt, A Baranauskaite, J Niebrzydowski, E Dokoupilova, ...
Arthritis & Rheumatology 70 (1), 40-48, 2018
1312018
Fenebrutinib versus placebo or Adalimumab in rheumatoid arthritis: A randomized, Double‐Blind, phase II trial
S Cohen, K Tuckwell, TR Katsumoto, R Zhao, J Galanter, C Lee, J Rae, ...
Arthritis & Rheumatology 72 (9), 1435-1446, 2020
892020
Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results
JS Smolen, JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, ...
Rheumatology 56 (10), 1771-1779, 2017
602017
Efficacy, pharmacokinetics and safety of subcutaneous versus intravenous CT-P13 in rheumatoid arthritis: a randomized phase I/III trial
R Westhovens, P Wiland, M Zawadzki, D Ivanova, AB Kasay, ...
Rheumatology 60 (5), 2277-2287, 2021
422021
OP0068 A phase 3 randomised controlled trial to compare CT-P13 with infliximab in patients with active rheumatoid arthritis: 54 week results from the planetra study
DH Yoo, A Racewicz, J Brzezicki, R Yatsyshyn, ET Arteaga, ...
Annals of the Rheumatic Diseases 72 (Suppl 3), A73-A73, 2013
412013
FRI0162 comparable safety and immunogenicity and sustained efficacy after transition to SB2 (An Infliximab Biosimilar) vs ongoing infliximab reference product in patients with …
JS Smolen, JY Choe, N Prodanovic, J Niebrzydowski, I Staykov, ...
Annals of the Rheumatic Diseases 75 (Suppl 2), 488-488, 2016
17*2016
Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms
B Doskaliuk, L Zaiats, R Yatsyshyn, P Gerych, N Cherniuk, O Zimba
Rheumatology International 40 (10), 1555-1569, 2020
152020
Influence of the complex treatment of hypothyroidism on the leptin level in patients with primary hypothyroidism
OM Didushko, PR Herych, IV Cherniavska, RI Yatsyshyn, VI Pankiv
Ìèð ìåäèöèíû è áèîëîãèè, 59-63, 2018
112018
COVID-19 from a rheumatology perspective: bibliometric and altmetric analysis
B Doskaliuk, R Yatsyshyn, I Klishch, O Zimba
Rheumatology International 41 (12), 2091-2103, 2021
92021
Prostate involvement in granulomatosis with polyangiitis
R Yatsyshyn, O Zimba, M Bahrii, B Doskaliuk, V Huryk
Rheumatology International 39 (7), 1269-1277, 2019
82019
Rheumatology in Ukraine
B Doskaliuk, O Zimba, R Yatsyshyn, V Kovalenko
Rheumatology International 40 (2), 175-182, 2020
72020
Challenges in diagnosis of limited granulomatosis with polyangiitis
O Zimba, B Doskaliuk, R Yatsyshyn, M Bahrii, M Hrytsevych
Rheumatology international 41 (7), 1337-1345, 2021
62021
AB0090 The biochemical basis of animal model of systemic sclerosis
B Doskaliuk, L Zaiats, R Yatsyshyn
Annals of the Rheumatic Diseases 80 (Suppl 1), 1074-1074, 2021
62021
AB0358 phenotypes of secondary sarcopenia in patients with rheumatoid arthritis
R Yatsyshyn, I Stoika
Annals of the Rheumatic Diseases 77 (Suppl 2), 1351-1351, 2018
52018
Modern aspects of medical educationin Ukraine
R Yatsyshyn, P Gerych, O Didushko
Ìåæäóíàðîäíûé ýíäîêðèíîëîãè÷åñêèé æóðíàë 13 (8), 630-631, 2017
52017
The system can't perform the operation now. Try again later.
Articles 1–20